Merits and liabilities of NSAID therapy.
The clinical usefulness of nonsteroidal anti-inflammatory drugs (NSAIDs) in antirheumatic therapy is discussed, along with the adverse reaction profile. The authors focus on the recent required gastrointestinal class labeling for NSAIDs as they impact on host population responses. Finally, the risk/benefit and cost/benefit considerations are reviewed.